entertainment -WSS

entertainment

author：comprehensive 2025-10-01 01:49:55 - browse：669

LONDON — AstraZeneca said on Monday that a new lung cancer treatment outperformed standard-of-care chemotherapy in a trial, but investors found the results less impressive than anticipated, sending company shares down in early trading.

Based on an interim analysis of a Phase 3 trial, the company said that the drug, datopotamab deruxtecan, led to improvement in progression-free survival in patients non-small cell lung cancer, a primary endpoint of the study. There was also a positive early trend on overall survival, with Susan Galbraith, AstraZeneca’s oncology leader, describing the results as “compelling evidence for the potential role” that the drug could play for patients.

But investors had been hoping for a clearer signal of benefit. Analysts noted that despite the success in progression-free survival, it was not described as a “clinically meaningful” improvement, which, as J.P. Morgan analysts wrote, “we believe the market would have liked to have seen.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Medicare must police algorithms in Medicare Advantage, Dems say

focus

WSS

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

Bill would allow buprenorphine prescription for addiction via telehealth

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

How to convince healthy people to buy insurance

Accuser says Kevin Spacey grope wasn't a caress: ‘It was like a cobra ... angry’

Gene therapy’s promise and the high cost of hope

hotspot

entertainment

hotspot

The high cost of giving birth even with insurance

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

Alkermes shareholders re

Pentagon will tighten controls on classified information after Discord leak

Medical leaders decry Supreme Court decision on affirmative action

What is microchimerism and how does it affect maternal health?

Jerome Adams on the need for new antivirals for Covid

Inari Medical to buy amputation prevention company LimFlow

Heart attack and stroke risk calculators need revising

Sarepta Duchenne therapy fails to meet primary endpoint in trial

knowledge

City of Memphis, police chief oppose effort to delay lawsuit in Tyre Nichols case

Myanmar's Supreme Court hears arguments in 2 appeals by ousted leader Aung San Suu Kyi

Kidney transplant patients stopped immunosuppressants in trial

What is microchimerism and how does it affect maternal health?

5 shark bites reported on Long Island as officials deploy surveillance drones

Philadelphia mass shooting: Few answers in apparently random attack as suspect charged with murder

knowledge

focus

knowledge

hotspot